New Canadian resource is designed to help prescribers make evidence-based decisions for treating infections in primary care and to promote better antibiotic stewardship.
A new survey suggests about three million Canadian adults are currently taking GLP-1 drugs such as Ozempic or Mounjaro and that many more would like to, but cost is a barrier.
American Society of Clinical Psychopharmacology Task Force identifies situations where discontinuation of certain psychotropic medications may be clinically indicated.
